Authors
Tallon K Milne, Kingsley K Donkor, Heidi E K Huttunen-Hennelly
Published in
Analytical biochemistry. Pages 116282. Oct 29, 2026. Epub Oct 29, 2026.
Abstract
Lipopolysaccharide (LPS) is a major component of the outer membrane of Gram-negative bacteria and the gatekeeper of the cell for many antimicrobial peptides (AMPs). Indolicidin (ID) is a cationic AMP isolated from cytoplasmic granules of bovine neutrophils. ID, however, is too toxic and hemolytic for therapeutic use. ID45, a novel ID derivative, was developed through amino acid substitution and displays an increased antimicrobial potential and reduced hemolysis. LPS, located in the bacterial envelope, is the suspected target receptor for ID and ID45. The interaction between ID or the derivative ID45 with LPS was characterized using capillary electrophoresis (CE). The binding constant (Kb) for the interaction between ID and LPS as well as ID45 and LPS, was determined using a range of CE techniques. Preincubation CE (PI-CE) was utilized over a temperature range of 20 - 30 °C to establish a Kb with thermodynamic parameters. PI-CE Kb values for the ID-LPS interaction (3.13 ± 0.77 × 104 M-1) and ID45-LPS interaction (14.83 ± 1.67 × 104 M-1) were determined at pH 7.2. Both interactions were thermodynamically favorable and determined to be due to electrostatic forces. CE Front Analysis (CE-FA) was also utilized to provide support to the PI-CE methodology. The results show that ID45 binds five times more strongly to LPS at equilibrium, perhaps explaining the observed increase in antimicrobial activity and decreased toxicity compared to ID. ID45 does have the potential to be a novel drug candidate.
PMID:
42956953
Bibliographic data and abstract were imported from PubMed on 30 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 3
- Comments 0